메뉴 건너뛰기




Volumn , Issue , 2005, Pages 831-840

Parenteral immunization induces mucosal protection: A challenge to the mucosal immunity paradigm

Author keywords

[No Author keywords available]

Indexed keywords


EID: 33947402861     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012491543-5/50049-8     Document Type: Chapter
Times cited : (6)

References (111)
  • 1
    • 0014834377 scopus 로고
    • Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and nonendemic cholera areas
    • Ahmed A., Bhattacharjee A.K., Mosley W.J. Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and nonendemic cholera areas. J. Immunol. 1970, 105:431-441.
    • (1970) J. Immunol. , vol.105 , pp. 431-441
    • Ahmed, A.1    Bhattacharjee, A.K.2    Mosley, W.J.3
  • 2
    • 0028944928 scopus 로고
    • Approaches to a vaccine against hepatitis A: Development and manufacture of inactivated vaccine
    • Suppl
    • Andre F.E. Approaches to a vaccine against hepatitis A: Development and manufacture of inactivated vaccine. J. Infect. Dis. 1995, 171:S33-S39. Suppl.
    • (1995) J. Infect. Dis. , vol.171
    • Andre, F.E.1
  • 4
    • 0036739777 scopus 로고    scopus 로고
    • Impact of meningococcal C conjugate vaccine in the UK
    • Balmer P., Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 2002, 51:717-722.
    • (2002) J. Med. Microbiol. , vol.51 , pp. 717-722
    • Balmer, P.1    Borrow, R.2    Miller, E.3
  • 5
    • 0018361826 scopus 로고
    • Rubella immunity gap: is intranasal vaccination the answer?
    • Banatvala J.E., Best J.M., O'Shea S., Waldman R.H. Rubella immunity gap: is intranasal vaccination the answer?. Lancet 1979, 1:970.
    • (1979) Lancet , vol.1 , pp. 970
    • Banatvala, J.E.1    Best, J.M.2    O'Shea, S.3    Waldman, R.H.4
  • 6
    • 0028855324 scopus 로고
    • The impact of conjugate vaccine on carriage of haemophilus influenzae type b
    • Barbour M.L., Mayon-White R.T., Coles C., Crook D.W.M. The impact of conjugate vaccine on carriage of haemophilus influenzae type b. J. Infect. Dis. 1995, 171:93-98.
    • (1995) J. Infect. Dis. , vol.171 , pp. 93-98
    • Barbour, M.L.1    Mayon-white, R.T.2    Coles, C.3    Crook, D.W.M.4
  • 7
    • 0030183712 scopus 로고    scopus 로고
    • Conjugate vaccines and the carriage of Haemophilus influenzae type b
    • Barbour M.L. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg. Infect. Dis. 1996, 2:176-182.
    • (1996) Emerg. Infect. Dis. , vol.2 , pp. 176-182
    • Barbour, M.L.1
  • 8
    • 0036451677 scopus 로고    scopus 로고
    • Safety and efficacy of the sevenvalent pneumococcal conjugate vaccine: evidence from Northern California
    • Black S., Shinefield H. Safety and efficacy of the sevenvalent pneumococcal conjugate vaccine: evidence from Northern California. Eur. J. Pediatr. 2002, 161(Suppl 2):S127-S131.
    • (2002) Eur. J. Pediatr. , vol.161 , Issue.SUPPL.2
    • Black, S.1    Shinefield, H.2
  • 9
    • 0025718942 scopus 로고
    • Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions
    • Blackwelder W.C., Storsaeter J., Olin P., Hallander H.O. Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. Am. J. Dis. Child. 1991, 145:1285-1289.
    • (1991) Am. J. Dis. Child. , vol.145 , pp. 1285-1289
    • Blackwelder, W.C.1    Storsaeter, J.2    Olin, P.3    Hallander, H.O.4
  • 10
    • 0032728718 scopus 로고    scopus 로고
    • Salivary antibodies following parenteral immunization of infant with a meningococcal serogroup A and C conjugated vaccine
    • Borrow R., Fox A.J., Cartwright K., Begg N.E., Jones D.M. Salivary antibodies following parenteral immunization of infant with a meningococcal serogroup A and C conjugated vaccine. Epidemiol. Infect. 1999, 123:201-208.
    • (1999) Epidemiol. Infect. , vol.123 , pp. 201-208
    • Borrow, R.1    Fox, A.J.2    Cartwright, K.3    Begg, N.E.4    Jones, D.M.5
  • 11
    • 0037460701 scopus 로고    scopus 로고
    • Effectiveness of meningococcal C conjugate vaccine in teenagers in England
    • Bose A., Coen P., Tully T., Viner R., Booy R Effectiveness of meningococcal C conjugate vaccine in teenagers in England. Lancet 2003, 391:675-676.
    • (2003) Lancet , vol.391 , pp. 675-676
    • Bose, A.1    Coen, P.2    Tully, T.3    Viner, R.4    Booy, R.5
  • 12
    • 0028817217 scopus 로고
    • Parenteral influenza vaccination induces a rapid systemic and local immune response
    • Brokstad K.A., Cox R.J., Olofsson J., Jonsson R., Haaheim L.R. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 1995, 171:198-203.
    • (1995) J. Infect. Dis. , vol.171 , pp. 198-203
    • Brokstad, K.A.1    Cox, R.J.2    Olofsson, J.3    Jonsson, R.4    Haaheim, L.R.5
  • 13
    • 0036534749 scopus 로고    scopus 로고
    • Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosae
    • Brokstad K.A., Eriksson J.C., Cox R.J., Tynning T., Ollofsson J., Jonsson R., Davidson A. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosae. J. Infect. Dis. 2002, 185:878-884.
    • (2002) J. Infect. Dis. , vol.185 , pp. 878-884
    • Brokstad, K.A.1    Eriksson, J.C.2    Cox, R.J.3    Tynning, T.4    Ollofsson, J.5    Jonsson, R.6    Davidson, A.7
  • 14
    • 0030001675 scopus 로고    scopus 로고
    • Lymphocyte homing and homeostasis
    • Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science 1996, 272:60-66.
    • (1996) Science , vol.272 , pp. 60-66
    • Butcher, E.C.1    Picker, L.J.2
  • 15
    • 0022588771 scopus 로고
    • Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
    • Clements M.L., Betts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 1986, 24:157-160.
    • (1986) J. Clin. Microbiol. , vol.24 , pp. 157-160
    • Clements, M.L.1    Betts, R.F.2    Tierney, E.L.3    Murphy, B.R.4
  • 16
    • 0025967987 scopus 로고
    • A prospective study on the association between serum antibodies to lipopolysaccharide and attack rate of shigellosis
    • Cohen D., Green M.S., Block C., Slepon R., Ofek I. A prospective study on the association between serum antibodies to lipopolysaccharide and attack rate of shigellosis. Clin. Microbiol. 1991, 29:386-389.
    • (1991) Clin. Microbiol. , vol.29 , pp. 386-389
    • Cohen, D.1    Green, M.S.2    Block, C.3    Slepon, R.4    Ofek, I.5
  • 18
    • 0036128729 scopus 로고    scopus 로고
    • Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine
    • Cohen M.B., Giannella R.A., Bean J., Taylor D.N., Parker S., Hoeper A., Wowk S., Hawkins J., Kochi S.K., Schiff G., Killeen K.P. Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine. Infect. Immun. 2002, 70(4):1965-1970.
    • (2002) Infect. Immun. , vol.70 , Issue.4 , pp. 1965-1970
    • Cohen, M.B.1    Giannella, R.A.2    Bean, J.3    Taylor, D.N.4    Parker, S.5    Hoeper, A.6    Wowk, S.7    Hawkins, J.8    Kochi, S.K.9    Schiff, G.10    Killeen, K.P.11
  • 20
    • 0003119244 scopus 로고
    • Rotavirus vaccines and vaccination potential
    • Springer-Verlag, Berlin, R. Ramig (Ed.)
    • Conner M.E., Matson D.O., Estes M.K. Rotavirus vaccines and vaccination potential. Rotaviruses 1994, 286-337. Springer-Verlag, Berlin. R. Ramig (Ed.).
    • (1994) Rotaviruses , pp. 286-337
    • Conner, M.E.1    Matson, D.O.2    Estes, M.K.3
  • 23
    • 0034026940 scopus 로고    scopus 로고
    • Conjugate pneumonococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity
    • Dagan R., Fraser D. Conjugate pneumonococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatr. Infect. Dis. J. 2000, (Suppl 19):S79-S87.
    • (2000) Pediatr. Infect. Dis. J. , Issue.SUPPL.19
    • Dagan, R.1    Fraser, D.2
  • 24
    • 0036372109 scopus 로고    scopus 로고
    • Pneumococcal conjugate vaccine (Prevnar, PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection
    • Darkes M.J., Plosker G.L. Pneumococcal conjugate vaccine (Prevnar, PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Paediatr. Drugs 2002, 4:609-630.
    • (2002) Paediatr. Drugs , vol.4 , pp. 609-630
    • Darkes, M.J.1    Plosker, G.L.2
  • 28
    • 0001918735 scopus 로고
    • Shigella species: bacillary dysentery
    • Churchill-Livingstone, London, G.L. Mandell, R.G. Douglas, J.E. Bennett (Eds.)
    • Dupont H.L. Shigella species: bacillary dysentery. Principles and Practice of Infectious Disease 1990, 1716-1722. Churchill-Livingstone, London. G.L. Mandell, R.G. Douglas, J.E. Bennett (Eds.).
    • (1990) Principles and Practice of Infectious Disease , pp. 1716-1722
    • Dupont, H.L.1
  • 29
    • 0031663270 scopus 로고    scopus 로고
    • Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination
    • El-Madhun A.S., Cox R.J., Soreide A., Oloffson J., Haaheim L.R. Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J. Infect. Dis. 1998, 178:933-939.
    • (1998) J. Infect. Dis. , vol.178 , pp. 933-939
    • El-madhun, A.S.1    Cox, R.J.2    Soreide, A.3    Oloffson, J.4    Haaheim, L.R.5
  • 30
    • 0036024376 scopus 로고    scopus 로고
    • Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid
    • Engstrom P.E., Gustafson, Granberg M., Engstron G.N. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid. Acta Odontol. Scand. 2002, 60:198-202.
    • (2002) Acta Odontol. Scand. , vol.60 , pp. 198-202
    • Engstrom, P.E.1    Gustafson Granberg, M.2    Engstron, G.N.3
  • 31
    • 0000458520 scopus 로고
    • A new antigen of B. typhosus, its relation to virulence and in active and passive immunization
    • Felix P., Pitt R. A new antigen of B. typhosus, its relation to virulence and in active and passive immunization. Lancet 1934, 2:186-191.
    • (1934) Lancet , vol.2 , pp. 186-191
    • Felix, P.1    Pitt, R.2
  • 32
    • 0017804801 scopus 로고
    • Response to experimental challenge in persons immunized with different rubella vaccines
    • Fogel A., Gerichter C., Barnea B., Handsher R., Heeger E. Response to experimental challenge in persons immunized with different rubella vaccines. J. Pediatrics 1978, 92:26-29.
    • (1978) J. Pediatrics , vol.92 , pp. 26-29
    • Fogel, A.1    Gerichter, C.2    Barnea, B.3    Handsher, R.4    Heeger, E.5
  • 33
    • 0026513987 scopus 로고
    • The outcome of congenital cytomegalovirus infection in relation to maternal antibody status
    • Fowler K.B., Stagno S., Pass R.F., Britt W.J., Bell T.J., Alford C.A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 1992, 326:663-667.
    • (1992) N. Engl. J. Med. , vol.326 , pp. 663-667
    • Fowler, K.B.1    Stagno, S.2    Pass, R.F.3    Britt, W.J.4    Bell, T.J.5    Alford, C.A.6
  • 34
    • 0035909667 scopus 로고    scopus 로고
    • The prevention of pneumococcal disease in children
    • Giebink G.C. The prevention of pneumococcal disease in children. N. Engl. J. Med. 2001, 345:1177-1183.
    • (2001) N. Engl. J. Med. , vol.345 , pp. 1177-1183
    • Giebink, G.C.1
  • 35
    • 0014531759 scopus 로고
    • Human immunity to the meningococcus-I. The role of humoral antibodies
    • Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus-I. The role of humoral antibodies. J. Exp. Med. 1969, 129:1307-1326.
    • (1969) J. Exp. Med. , vol.129 , pp. 1307-1326
    • Goldschneider, I.1    Gotschlich, E.C.2    Artenstein, M.S.3
  • 36
    • 0030061535 scopus 로고    scopus 로고
    • Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly
    • Gorse G.J., Otto E.E., Powers D.C., Chambers G.W., Eickhoff C.S., Newman F.K. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J. Infect. Dis. 1996, 173:285-290.
    • (1996) J. Infect. Dis. , vol.173 , pp. 285-290
    • Gorse, G.J.1    Otto, E.E.2    Powers, D.C.3    Chambers, G.W.4    Eickhoff, C.S.5    Newman, F.K.6
  • 37
    • 0014528517 scopus 로고
    • Human immunity to the meningococcus-V. The effect of immunization with meningococcal group C polysaccharide vaccine
    • Gotschlich E.C., Goldschneider I., Artenstein M.S. Human immunity to the meningococcus-V. The effect of immunization with meningococcal group C polysaccharide vaccine. J. Exp. Med. 1969, 129:1385-1395.
    • (1969) J. Exp. Med. , vol.129 , pp. 1385-1395
    • Gotschlich, E.C.1    Goldschneider, I.2    Artenstein, M.S.3
  • 40
    • 0031816225 scopus 로고    scopus 로고
    • Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers
    • Gupta R.K., Taylor D.N., Bryla D.A., Robbins J.B., Szu S.C. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers. Infect. Immun. 1998, 66(7):3095-3099.
    • (1998) Infect. Immun. , vol.66 , Issue.7 , pp. 3095-3099
    • Gupta, R.K.1    Taylor, D.N.2    Bryla, D.A.3    Robbins, J.B.4    Szu, S.C.5
  • 41
    • 0033561766 scopus 로고    scopus 로고
    • Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus
    • Herremans T.D., Reimerink J.H., Buisman A.M., Kimman T.G., Loopmans M.P. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J. Immunol. 1999, 162:5011-5018.
    • (1999) J. Immunol. , vol.162 , pp. 5011-5018
    • Herremans, T.D.1    Reimerink, J.H.2    Buisman, A.M.3    Kimman, T.G.4    Loopmans, M.P.5
  • 42
    • 0028913819 scopus 로고
    • Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines
    • Kauppi M., Eskola J., Kayhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr. Infect. Dis. J. 1995, 14:286-294.
    • (1995) Pediatr. Infect. Dis. J. , vol.14 , pp. 286-294
    • Kauppi, M.1    Eskola, J.2    Kayhty, H.3
  • 43
    • 0023931702 scopus 로고
    • Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri
    • Keren D.F., McDonald R.A., Carey J.L. Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri. Infect. Immun. 1988, 56:910-915.
    • (1988) Infect. Immun. , vol.56 , pp. 910-915
    • Keren, D.F.1    McDonald, R.A.2    Carey, J.L.3
  • 44
    • 0014495251 scopus 로고
    • Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
    • Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., Parrot R.H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89:422-434.
    • (1969) Am. J. Epidemiol. , vol.89 , pp. 422-434
    • Kim, H.W.1    Canchola, J.G.2    Brandt, C.D.3    Pyles, G.4    Chanock, R.M.5    Jensen, K.6    Parrot, R.H.7
  • 46
    • 84882838075 scopus 로고
    • Studies on Vi antigen: Immunization of human beings with purified Vi Antigen
    • Landy M. Studies on Vi antigen: Immunization of human beings with purified Vi Antigen. Am. J. Hygiene 1964, 60:62.
    • (1964) Am. J. Hygiene , vol.60 , pp. 62
    • Landy, M.1
  • 49
    • 0027446495 scopus 로고
    • Live vaccines against cholera: an update
    • Levine M.M., Kapper J. Live vaccines against cholera: an update. Vaccine 1993, 11:207-212.
    • (1993) Vaccine , vol.11 , pp. 207-212
    • Levine, M.M.1    Kapper, J.2
  • 50
    • 0141781018 scopus 로고    scopus 로고
    • Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108
    • Liang W., Wang S., Y F., Zhang L., Qi G., Liu Y., Gao S., Kan B. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect. Immun. 2003, 71:5498-5504.
    • (2003) Infect. Immun. , vol.71 , pp. 5498-5504
    • Liang, W.1    Wang, S.Y.F.2    Zhang, L.3    Qi, G.4    Liu, Y.5    Gao, S.6    Kan, B.7
  • 55
    • 0000240393 scopus 로고
    • Limitation of fecal and pharyngeal poliovirus excretion in salk-vaccinated children
    • Marine W.M., Chin T.D.Y., Gravelle C.R. Limitation of fecal and pharyngeal poliovirus excretion in salk-vaccinated children. Am. J. Hyg. 1962, 76:173-195.
    • (1962) Am. J. Hyg. , vol.76 , pp. 173-195
    • Marine, W.M.1    Chin, T.D.Y.2    Gravelle, C.R.3
  • 56
    • 0030945218 scopus 로고    scopus 로고
    • Serum levels of rubella virus antibodies indicating immunity: Response to vaccination of subjects with low or undetectable antibody concentrations
    • Matter L., Kogelschatz K., Germann D. Serum levels of rubella virus antibodies indicating immunity: Response to vaccination of subjects with low or undetectable antibody concentrations. J. Infect. Dis. 1997, 175:749-755.
    • (1997) J. Infect. Dis. , vol.175 , pp. 749-755
    • Matter, L.1    Kogelschatz, K.2    Germann, D.3
  • 57
    • 0033394801 scopus 로고    scopus 로고
    • Immunogenicity and impact on nasopharyngeal carriage of a nonvalent pneumococcal conjugate vaccine
    • Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman O.P. Immunogenicity and impact on nasopharyngeal carriage of a nonvalent pneumococcal conjugate vaccine. J. Infect Dis. 1999, 180:1171-1176.
    • (1999) J. Infect Dis. , vol.180 , pp. 1171-1176
    • Mbelle, N.1    Huebner, R.E.2    Wasas, A.D.3    Kimura, A.4    Chang, I.5    Klugman, O.P.6
  • 58
    • 0018745032 scopus 로고
    • Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues
    • McDermott M.R., Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. J. Immunol. 1979, 122:1892-1898.
    • (1979) J. Immunol. , vol.122 , pp. 1892-1898
    • McDermott, M.R.1    Bienenstock, J.2
  • 59
    • 0038752646 scopus 로고    scopus 로고
    • Risk of vaccine failure after Haemophilus influenzae type b(Hib) combination vaccines with acellular pertussis
    • McVernon J., Andrews N., Slack M.P.E., Ramsay M.E. Risk of vaccine failure after Haemophilus influenzae type b(Hib) combination vaccines with acellular pertussis. Lancet 2003, 361:1521-1523.
    • (2003) Lancet , vol.361 , pp. 1521-1523
    • McVernon, J.1    Andrews, N.2    Slack, M.P.E.3    Ramsay, M.E.4
  • 62
    • 0029162013 scopus 로고
    • Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
    • Moldoveanu Z., Clement M.L., Primie S.J., Murphy B.R., Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995, 13:1006-1012.
    • (1995) Vaccine , vol.13 , pp. 1006-1012
    • Moldoveanu, Z.1    Clement, M.L.2    Primie, S.J.3    Murphy, B.R.4    Mestecky, J.5
  • 63
    • 0030175812 scopus 로고    scopus 로고
    • Inactivated poliovirus vaccine: past and present experience
    • Murdin A.D., Barreto L., Plotkin S. Inactivated poliovirus vaccine: past and present experience. Vaccine 1996, 14:735-746.
    • (1996) Vaccine , vol.14 , pp. 735-746
    • Murdin, A.D.1    Barreto, L.2    Plotkin, S.3
  • 64
    • 0036884113 scopus 로고    scopus 로고
    • Intussusception, rotavirus and oral vaccines: summary of a workshop
    • Myers P.G. Intussusception, rotavirus and oral vaccines: summary of a workshop. Pediatrics 2002, 110:e17.
    • (2002) Pediatrics , vol.110
    • Myers, P.G.1
  • 65
    • 0028670659 scopus 로고
    • Epidemiology of pertussis in Denmark: the impact of herd immunity
    • Neilsen A., Larsen S.O. Epidemiology of pertussis in Denmark: the impact of herd immunity. Int. J. Epidemiol. 1994, 23:1300-1307.
    • (1994) Int. J. Epidemiol. , vol.23 , pp. 1300-1307
    • Neilsen, A.1    Larsen, S.O.2
  • 66
    • 0029154497 scopus 로고
    • The effectiveness of vaccination against influenza in healthy working adults
    • Nichol K.L., Lind A., Margolis K.L. The effectiveness of vaccination against influenza in healthy working adults. N. Engl. J. Med. 1995, 333:889-893.
    • (1995) N. Engl. J. Med. , vol.333 , pp. 889-893
    • Nichol, K.L.1    Lind, A.2    Margolis, K.L.3
  • 68
    • 0344549183 scopus 로고    scopus 로고
    • Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies
    • Nieminen T., Kayhty H., Leroy O., Eskola J. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies. Pediatr. Infect Dis. J. 1999, 18:764-772.
    • (1999) Pediatr. Infect Dis. J. , vol.18 , pp. 764-772
    • Nieminen, T.1    Kayhty, H.2    Leroy, O.3    Eskola, J.4
  • 69
    • 0035884241 scopus 로고    scopus 로고
    • Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York and Oregon: data from 3 healthy plans
    • Nordin J., Mullooley J., Pobledte S., Strikas R., Petrucci R., Wei F., Rush B., Safirstein B., Wheeler D., Nichol L.D. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York and Oregon: data from 3 healthy plans. J. Infect. Dis. 2001, 184:665-670.
    • (2001) J. Infect. Dis. , vol.184 , pp. 665-670
    • Nordin, J.1    Mullooley, J.2    Pobledte, S.3    Strikas, R.4    Petrucci, R.5    Wei, F.6    Rush, B.7    Safirstein, B.8    Wheeler, D.9    Nichol, L.D.10
  • 70
    • 0036171847 scopus 로고    scopus 로고
    • The pneumococcus: carriage, disease and conjugate vaccines
    • Obaro S., Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J. Microbiol. 2002, 51:98-104.
    • (2002) J. Microbiol. , vol.51 , pp. 98-104
    • Obaro, S.1    Adegbola, R.2
  • 71
    • 0035091025 scopus 로고    scopus 로고
    • Disease transmission, routes, contributing factors and herd immunity
    • O'Brien K. Disease transmission, routes, contributing factors and herd immunity. IJCP Suppl. 2001, 118:5-7.
    • (2001) IJCP Suppl. , vol.118 , pp. 5-7
    • O'Brien, K.1
  • 72
    • 0015216837 scopus 로고
    • Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus
    • Ogra P.L., Kerr-Grant D., Umana G., Dzierba J., Weintraub D. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N. Engl. J. Med. 1971, 285:1333-1339.
    • (1971) N. Engl. J. Med. , vol.285 , pp. 1333-1339
    • Ogra, P.L.1    Kerr-grant, D.2    Umana, G.3    Dzierba, J.4    Weintraub, D.5
  • 73
    • 0029073588 scopus 로고
    • Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines
    • Ogra P.L. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines. Ann. N.Y. Acad. Sci. 1995, 754:97-107.
    • (1995) Ann. N.Y. Acad. Sci. , vol.754 , pp. 97-107
    • Ogra, P.L.1
  • 74
    • 0029051853 scopus 로고
    • Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: pertussis vaccination
    • Olin P. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: pertussis vaccination. Ann. N.Y. Acad. Sci. 1993, 754:273-277.
    • (1993) Ann. N.Y. Acad. Sci. , vol.754 , pp. 273-277
    • Olin, P.1
  • 79
    • 0026725878 scopus 로고
    • Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines
    • Petola H., Kilpi T., Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 1992, 340:592-594.
    • (1992) Lancet , vol.340 , pp. 592-594
    • Petola, H.1    Kilpi, T.2    Anttila, M.3
  • 80
    • 0021019358 scopus 로고
    • Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule
    • Pichichero M.E., Insel R.A. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. J. Allergy Clin. Immunol. 1983, 72:481-486.
    • (1983) J. Allergy Clin. Immunol. , vol.72 , pp. 481-486
    • Pichichero, M.E.1    Insel, R.A.2
  • 82
    • 0028808713 scopus 로고
    • A new typhoid vaccine composed of the Vi capsular polysaccharide
    • Plotkin S.A., Bouveret-LeCam N. A new typhoid vaccine composed of the Vi capsular polysaccharide. Arch. Intern. Med. 1995, 155:2293-2299.
    • (1995) Arch. Intern. Med. , vol.155 , pp. 2293-2299
    • Plotkin, S.A.1    Bouveret-leCam, N.2
  • 83
    • 0015916061 scopus 로고
    • Immunologic properties of RA27/3 rubella virus vaccine
    • Plotkin S.A., Farquhar J.D., Ogra P.L. Immunologic properties of RA27/3 rubella virus vaccine. JAMA 1973, 225:585-590.
    • (1973) JAMA , vol.225 , pp. 585-590
    • Plotkin, S.A.1    Farquhar, J.D.2    Ogra, P.L.3
  • 84
    • 0030793282 scopus 로고    scopus 로고
    • Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis
    • Plotkin S.A. Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis. Rev. Med. Virol. 1997, 7:75-81.
    • (1997) Rev. Med. Virol. , vol.7 , pp. 75-81
    • Plotkin, S.A.1
  • 85
    • 0030061535 scopus 로고    scopus 로고
    • Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly
    • Powers D.C., Gorse G.J., Otto E.E., Chambers G.W., Eichoff C.S., Newman F.K. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J. Infect. Dis. 1996, 173:285-290.
    • (1996) J. Infect. Dis. , vol.173 , pp. 285-290
    • Powers, D.C.1    Gorse, G.J.2    Otto, E.E.3    Chambers, G.W.4    Eichoff, C.S.5    Newman, F.K.6
  • 86
    • 0042198664 scopus 로고    scopus 로고
    • Why the rise in Haemophilus Influenza type b infections?
    • Preston N.W. Why the rise in Haemophilus Influenza type b infections?. Lancet 2003, 362:330-331.
    • (2003) Lancet , vol.362 , pp. 330-331
    • Preston, N.W.1
  • 88
    • 0025775165 scopus 로고
    • Passive transfer of local immunity to influenza virus infection by IgA antibody
    • Renegar K.B., Small P.A. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 1991, 146:1972-1978.
    • (1991) J. Immunol. , vol.146 , pp. 1972-1978
    • Renegar, K.B.1    Small, P.A.2
  • 89
    • 0030577062 scopus 로고    scopus 로고
    • The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines
    • Robbins J.B., Schneerson R., Anderson P., Smith D.H. The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines. JAMA 1996, 276:1181-1185.
    • (1996) JAMA , vol.276 , pp. 1181-1185
    • Robbins, J.B.1    Schneerson, R.2    Anderson, P.3    Smith, D.H.4
  • 91
    • 0029310641 scopus 로고
    • Perspective: Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum
    • Robbins J.B., Schneerson R., Szu S.C. Perspective: Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 1995, 171:1387-1398.
    • (1995) J. Infect. Dis. , vol.171 , pp. 1387-1398
    • Robbins, J.B.1    Schneerson, R.2    Szu, S.C.3
  • 92
    • 10744230712 scopus 로고    scopus 로고
    • Safety and efficacy of meningococcal group C conjugate vaccine
    • Ruggeberg J., Heath P.T. Safety and efficacy of meningococcal group C conjugate vaccine. Expert Opin. Drug. Saf. 2003, 2:7-19.
    • (2003) Expert Opin. Drug. Saf. , vol.2 , pp. 7-19
    • Ruggeberg, J.1    Heath, P.T.2
  • 94
    • 0028124110 scopus 로고
    • Cholera control
    • Sack D.A. Cholera control. Lancet 1994, 344:616-617.
    • (1994) Lancet , vol.344 , pp. 616-617
    • Sack, D.A.1
  • 96
    • 0017337335 scopus 로고
    • Control of influenza and poliomyelitis with killed virus vaccines
    • Salk J., Salk D. Control of influenza and poliomyelitis with killed virus vaccines. Science 1977, 195:834-847.
    • (1977) Science , vol.195 , pp. 834-847
    • Salk, J.1    Salk, D.2
  • 97
    • 0036104085 scopus 로고    scopus 로고
    • Host-pathogen interactions: the seduction of molecular cross tal
    • Sansonetti P. Host-pathogen interactions: the seduction of molecular cross tal. Gut 2002, 50(Suppl 3):1112-1118.
    • (2002) Gut , vol.50 , Issue.SUPPL.3 , pp. 1112-1118
    • Sansonetti, P.1
  • 98
    • 0026632876 scopus 로고
    • Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease
    • Siber G.R., Thompson C., Reid G.R., Almeido-Hill J., Zacher B., Wolff M., Santosham M. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J. Infect. Dis. 1992, 165(Suppl 1):S129-S133.
    • (1992) J. Infect. Dis. , vol.165 , Issue.SUPPL.1
    • Siber, G.R.1    Thompson, C.2    Reid, G.R.3    Almeido-hill, J.4    Zacher, B.5    Wolff, M.6    Santosham, M.7
  • 99
    • 0042068077 scopus 로고    scopus 로고
    • Why the rise in Haemophilus influenzae type b infections?
    • Silfverdal S.A., Bodin L., Olcén P. Why the rise in Haemophilus influenzae type b infections?. Lancet 2003, 362:331.
    • (2003) Lancet , vol.362 , pp. 331
    • Silfverdal, S.A.1    Bodin, L.2    Olcén, P.3
  • 102
    • 0025121089 scopus 로고
    • Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease
    • Snydman D.R. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. Rev. Infect. Dis. 1990, 12(suppl 7):S839-S848.
    • (1990) Rev. Infect. Dis. , vol.12 , Issue.SUPPL. 7
    • Snydman, D.R.1
  • 105
    • 0025315096 scopus 로고
    • Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses
    • Tarkowski A., Lue C., Moldoveanu Z., Kiyono H., McGhee J.R., Mestecky J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J. Immunol. 1990, 144:3770-3778.
    • (1990) J. Immunol. , vol.144 , pp. 3770-3778
    • Tarkowski, A.1    Lue, C.2    Moldoveanu, Z.3    Kiyono, H.4    McGhee, J.R.5    Mestecky, J.6
  • 106
    • 19144372367 scopus 로고    scopus 로고
    • Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus
    • Wang J.B., Adler S.P., Hempfling S., Burke R.L., Duliege A.M., Starr S.E., Plotkin S.A. Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus. J. Infect. Dis. 1996, 174:387-392.
    • (1996) J. Infect. Dis. , vol.174 , pp. 387-392
    • Wang, J.B.1    Adler, S.P.2    Hempfling, S.3    Burke, R.L.4    Duliege, A.M.5    Starr, S.E.6    Plotkin, S.A.7
  • 107
    • 0026012883 scopus 로고
    • New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection
    • Winner L., Mach J., Weltzin R., Mekalanos J.J., Kraehenbuhl J.P., Neutra M.R. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 1991, 59(3):977-982.
    • (1991) Infect. Immun. , vol.59 , Issue.3 , pp. 977-982
    • Winner, L.1    Mach, J.2    Weltzin, R.3    Mekalanos, J.J.4    Kraehenbuhl, J.P.5    Neutra, M.R.6
  • 108
    • 0041402774 scopus 로고    scopus 로고
    • Cell-mediated immunity to respiratory virus infections
    • Woodland D.L. Cell-mediated immunity to respiratory virus infections. Curr. Opin. Immunol. 2003, 15:430-435.
    • (2003) Curr. Opin. Immunol. , vol.15 , pp. 430-435
    • Woodland, D.L.1
  • 109
    • 0033624827 scopus 로고    scopus 로고
    • Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents
    • Zhang Q., Choo S., Everard J., Jennings R., Finn A. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect. Immun. 2000, 68:2692-2697.
    • (2000) Infect. Immun. , vol.68 , pp. 2692-2697
    • Zhang, Q.1    Choo, S.2    Everard, J.3    Jennings, R.4    Finn, A.5
  • 110
    • 0034967971 scopus 로고    scopus 로고
    • Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom
    • Zhang Q., Lakshman R., Burkinshaw R., Choo S., Everard J., Akhtar S, Fi A Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom. Infect. Immun. 2001, 69:4337-4341.
    • (2001) Infect. Immun. , vol.69 , pp. 4337-4341
    • Zhang, Q.1    Lakshman, R.2    Burkinshaw, R.3    Choo, S.4    Everard, J.5    Akhtar, S.6    Fi, A.7
  • 111


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.